ES2311544T3 - Imidazoles sustituidos como agonistas o antagonistas duales de histamina h1 y h3. - Google Patents

Imidazoles sustituidos como agonistas o antagonistas duales de histamina h1 y h3. Download PDF

Info

Publication number
ES2311544T3
ES2311544T3 ES01971115T ES01971115T ES2311544T3 ES 2311544 T3 ES2311544 T3 ES 2311544T3 ES 01971115 T ES01971115 T ES 01971115T ES 01971115 T ES01971115 T ES 01971115T ES 2311544 T3 ES2311544 T3 ES 2311544T3
Authority
ES
Spain
Prior art keywords
group
alkyl
imidazols
histamine
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01971115T
Other languages
English (en)
Spanish (es)
Inventor
Neng-Yang Shih
Robert G Aslanian
John J Piwinski
Andrew T Lupo Jr
Adriano Afonso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2311544T3 publication Critical patent/ES2311544T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES01971115T 2000-09-20 2001-09-18 Imidazoles sustituidos como agonistas o antagonistas duales de histamina h1 y h3. Expired - Lifetime ES2311544T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23403800P 2000-09-20 2000-09-20

Publications (1)

Publication Number Publication Date
ES2311544T3 true ES2311544T3 (es) 2009-02-16

Family

ID=22879621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01971115T Expired - Lifetime ES2311544T3 (es) 2000-09-20 2001-09-18 Imidazoles sustituidos como agonistas o antagonistas duales de histamina h1 y h3.

Country Status (14)

Country Link
US (1) US6528522B2 (enExample)
EP (1) EP1318993B1 (enExample)
JP (1) JP2004509869A (enExample)
CN (1) CN1558907A (enExample)
AR (1) AR031612A1 (enExample)
AT (1) ATE405557T1 (enExample)
AU (1) AU2001291040A1 (enExample)
CA (1) CA2422210C (enExample)
DE (1) DE60135471D1 (enExample)
ES (1) ES2311544T3 (enExample)
HK (1) HK1052180A1 (enExample)
MX (1) MXPA03002445A (enExample)
MY (1) MY120281A (enExample)
WO (1) WO2002024657A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
RU2015139700A (ru) * 2013-02-19 2017-03-27 Икан Скул Оф Медсин Эт Маунт Синай Трициклические гетероциклические соединения в качестве противораковых средств
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
JP6966425B2 (ja) 2015-09-09 2021-11-17 アイカーン スクール オブ メディスン アット マウント サイナイIcahn School of Medicine at Mt. Sinai 抗がん剤としての複素環式の限定された三環系スルホンアミド
JP6955485B2 (ja) 2015-09-09 2021-10-27 アイカーン スクール オブ メディスン アット マウント サイナイＩｃａｈｎ Ｓｃｈｏｏｌ ｏｆ Ｍｅｄｉｃｉｎｅ ａｔ Ｍｔ． Ｓｉｎａｉ 抗がん剤としての複素環式の限定された三環系スルホンアミド

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586562B1 (fr) 1985-09-02 1989-03-10 Inst Nat Sante Rech Med Composition pharmaceutique contenant de l'a-methylhistamine
GB8916947D0 (en) 1989-07-25 1989-09-13 Smith Kline French Lab Medicaments
EP0448765B1 (de) 1990-03-30 1994-08-17 HEUMANN PHARMA GMBH & CO Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung
GB9115740D0 (en) 1991-07-20 1991-09-04 Smithkline Beecham Plc Medicaments
AU662588B2 (en) 1991-12-18 1995-09-07 Schering Corporation Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine H3 agonists/antagonists
US5352707A (en) 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
NZ276883A (en) 1993-11-15 1998-08-26 Schering Corp 1h-imidazol-4-yl)alkyl]benzene derivatives
FR2732017B1 (fr) 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
PT1019050E (pt) 1997-06-24 2002-09-30 Novo Nordisk As Utilizacao de agonisticos e de antagonisticos de somatostatina para o tratamento de doencas associadas ao olho
US5869479A (en) 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses

Also Published As

Publication number Publication date
WO2002024657A3 (en) 2002-07-11
MXPA03002445A (es) 2003-06-19
MY120281A (en) 2005-09-30
EP1318993B1 (en) 2008-08-20
CA2422210C (en) 2009-10-27
JP2004509869A (ja) 2004-04-02
CA2422210A1 (en) 2002-03-28
US20020082272A1 (en) 2002-06-27
EP1318993A2 (en) 2003-06-18
DE60135471D1 (de) 2008-10-02
CN1558907A (zh) 2004-12-29
US6528522B2 (en) 2003-03-04
ATE405557T1 (de) 2008-09-15
AU2001291040A1 (en) 2002-04-02
WO2002024657A2 (en) 2002-03-28
AR031612A1 (es) 2003-09-24
HK1052180A1 (zh) 2003-09-05

Similar Documents

Publication Publication Date Title
AR121419A1 (es) Piridazinonas como inhibidoras de parp7
MX2021009763A (es) Derivados de 3-(1-oxo-5-(piperidin-4-il)isoindolin-2-il)piperidina -2,6-diona y usos de los mismos.
CO5640117A2 (es) Derivados de 2,4-diamonopirimidina
AR104716A1 (es) Agonistas de triazol del receptor apj
AR051387A1 (es) Analogos de anilino-pirimidina
CO6150182A2 (es) Modulares de benzofuro y benzotienopirimidina del receptor h4 de histamina
PE20040835A1 (es) Administracion combinada de una indolina con un agente quimioterapeutico para transtornos de proliferacion celular
ES473451A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
CO6190611A2 (es) Derivados de espirocromanona sustituidos
NO20050429L (no) Substituert kinolin-CCR5-reseptorantagonister
ATE433967T1 (de) 2-aminopyridin-substituierteheterocyclen als inhibitoren der zellulären proliferation
AR082864A2 (es) Preparacion de compuestos de aminopirimidina
EA200300777A1 (ru) N-фенпропилциклопентил-замещенные производные глутарамида в качестве nep ингибиторов для fsad
RU2008147095A (ru) Макролидные производные
PE20030761A1 (es) Derivados del 7-amino-benzotiazol
ECSP19043231A (es) Inhibidores de la tirosina quinasa de bruton
PE20090444A1 (es) Eteres heterociclicos sustituidos y su uso en trastornos del snc
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
WO2009095792A3 (en) Substituted heteroarylamide diazepinopyrimidone derivatives
AR116906A1 (es) Derivados de heteroarilo bicíclico
TW200613297A (en) Pyrazole derivatives
WO2004020584A3 (en) Antagonists of chemokine receptors
HRP20030610B1 (en) Process for the preparation of mesylates of piperazine derivatives
AR125188A1 (es) Inhibidores del vmat2 y métodos de uso
PL1692098T3 (pl) Pochodna alfa-ketomidu oraz sposób jej wytwarzania i zastosowanie